Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3437 of 6351
-
Liver surgery combo fails to show clear survival edge in advanced colorectal cancer
Disease control Stopped earlyThis randomized phase II trial studies how well liver surgery and chemotherapy compared to chemotherapy alone work in treating patients with colorectal cancer that has spread to the liver (liver metastases) that can be removed by surgery and that has spread to the lungs (lung met…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Experimental antibody takes aim at tough lymphoma
Disease control OngoingThis phase I trial studies the side effects and best dose of anti-inducible T-cell co-stimulator (ICOS) monoclonal antibody MEDI-570 in treating patients with peripheral T-cell lymphoma follicular variant or angioimmunoblastic T-cell lymphoma that has returned after a period of i…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Exercise program aims to reverse frailty in seniors
Knowledge-focused CompletedOlder people are a very heterogeneous population characterized by a high interindividual variability. Functional abilities (walking, transfers ...) used to classify individuals aged (Lalive d'épinay et al., 1999) in three categories: independent, frail and dependent (HAS, 2005). …
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Experimental drug shows promise for rare immune disorder, but study cut short
Disease control Stopped earlyThis study is designed to provide long-term CDZ173 treatment, a selective PI3Kδ inhibitor, to the patients with genetically activated PI3Kδ, i.e., patients with APDS/PASLI who participated in the CCDZ173X2201 study or who were treated previously with PI3Kδ inhibitors other than C…
Phase 2/3 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Blood test may predict cancer recurrence in colorectal patients
Knowledge-focused OngoingThis observational study will evaluate circulating tumor DNA (ctDNA) as a prognostic marker and as a monitor of disease recurrence in stage III colorectal cancer (CRC).
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Exercise and protein: a One-Two punch against Age-Related muscle loss?
Disease control CompletedThis project will investigate the synergistic effects of Aerobic and Resistance type Exercise, in combination with Protein Supplementation, on; Body Composition, Musculoskeletal Functioning, Nutritional Status and Quality of Life in Age-related Sarcopenia.
Sponsor: Liverpool Hope University • Aim: Disease control
Last updated Jun 26, 2026 16:44 UTC
-
Zapping the brain to quiet knee pain: new study tests two non-invasive techniques
Symptom relief OngoingThe purpose of this study is to investigate the effects of transcranial direct current stimulation (tDCS) in conjunction with transcranial ultrasound (TUS) on pain perception and functional limitations in people with osteoarthritis of the knee. The investigators hypothesize that …
Sponsor: Spaulding Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Sleep loss may worsen heart risks in women, study finds
Knowledge-focused CompletedThe overall goal of this project is to test the hypothesis that long-term, sustained sleep restriction (SR), in women, will lead to increased cardio-metabolic risk. This will be characterized by increases in visceral adiposity, unhealthy lifestyle behaviors (poor dietary quality …
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Can a breathing gadget calm anxious teens?
Symptom relief Stopped earlyThis study will test the efficiency of the Freespira Breathing System in youth.
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Can common painkillers ease Parkinson's nerve pain? new study investigates.
Symptom relief CompletedThis study will be conducted in three parallel groups receiving oxycodone, levodopa or placebo, administered as an add-on therapy, in addition to the usual antiparkinsonian treatment. As this study focuses on chronic central neuropathic pain caused by PD, the effects of study tre…
Phase 2/3 • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Exercise before bone cancer surgery shows promise
Symptom relief OngoingThis clinical trial studies how well supervised exercise works in improving physical fitness before surgery in patients with bone cancer that can be removed by surgery. Supervised exercise may provide better short-term physical fitness in patients with bone cancer.
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Could estrogen shield transplanted kidneys?
Disease control OngoingIschemia perfusion injury (IRI) is a major cause of organ injury during kidney transplantation. Currently there are no treatments for IRI other than dialysis. Preliminary studies in female mice have found protection from IRI when given short term estrogen supplements. This study …
Phase 1/2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Safer antibiotic dosing could protect kidneys in cystic fibrosis patients
Disease control CompletedThe purpose of this study is to find the safest and most effective way to administer IV antibiotics to treat acute pulmonary exacerbations (APEs) in patients with cystic fibrosis (CF) that are caused by pathogens, like Pseudomonas aeruginosa. This study will test the safety and e…
Phase 4 • Sponsor: National Jewish Health • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Single-Cell tech could unlock secrets of a highly effective vaccine
Knowledge-focused CompletedThe immune system is composed of diverse cell types with different functions that act together in order to defend against infection. This pilot study will test a new technology for studying these many different cell types at very large numbers at the level of individual cells. Th…
Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
New combo therapy tested for hard-to-treat colorectal cancer
Disease control CompletedThis is a Phase 1b, open label, dose-finding study to determine the Maximum Tolerated Dose (MTD) of MEK162 in combination with mFOLFIRI, and to evaluate the response rate, clinical benefit rate and additional safety parameters of the treatment combination
Phase 1 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New testing method may guide targeted treatments for young leukemia patients
Knowledge-focused OngoingThis research study is seeking to gain new knowledge about Recurrent, Refractory, or High Risk Leukemias in children and young adults. This study is evaluating the use of specialized testing called leukemia profiling. Once the profiling is performed, the results are evaluated by…
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Blood RNA may reveal who responds to heart failure treatment
Knowledge-focused OngoingThe purpose of this American Heart Association-funded and NIH-funded study is to examine circulating RNAs in the acute CHF setting, how they change with decongestive therapy, and their function in vitro and in vivo. The investigators are testing the hypothesis that ex-RNA levels…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
New combo therapy shows promise in early trial for liver-metastatic colorectal cancer
Disease control CompletedThe purpose of this research study is: * To find out how safe the study drug, pembrolizumab, is when combined with stereotactic body radiotherapy (SBRT) to the liver. * To see how well subjects can tolerate treatment with pembrolizumab and SBRT. * To find out how often colorecta…
Phase 1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Radiation boosts immunotherapy in melanoma? small trial halted early
Disease control Stopped earlyAround 13,000 participants are diagnosed with melanoma in the UK each year and that number is growing quicker than any other cancer. About 20% of participants will see their cancer return following their initial treatment and at present would survive a median time of 912 months. …
Phase 2 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Three months of gym training shows promise for blood sugar control
Disease control CompletedThe "Bialystok Exercise Study in Diabetes" (BESD), is an exercise intervention study, conducted by the Department of Endocrinology, Diabetology and Internal Medicine and Clinical Research Centre of the Medical University of Bialystok. In the project, sedentary males at different …
Sponsor: Medical University of Bialystok • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC